Drug-drug interaction study of NS-580 in Healthy male subjects (Phase I Study)
Phase 1
- Conditions
- Healthy volunteer
- Registration Number
- JPRN-jRCT2071220031
- Lead Sponsor
- Higashioka Masaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
1) Provided written informed consent
2) Japanese male subjects
3) Body mass index (BMI) >=18.5 and <25.0 kg/m2 at the time of screening tests and hospitalization
Exclusion Criteria
1) Subjects with active systemic infections
2) Subjects with a history of drug and food allergies and hypersensitivity
3) Subjects who collected 200 mL or more of whole blood or component blood within 2 weeks before administration of the study drug
4) Subjects who are contraindicated for itraconazole, caffeine, triazolam, and rosuvastatin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method